Presented ByProf. Lajos Pusztai, Yale School of Medicine, CT, USA
TrialPhase 3, KEYNOTE-522 ConferenceASCO 2022
5 August, 2022 11:26
Presented ByProf. Peter Schmid, Barts Cancer Institute, UK
TrialPhase 3, KEYNOTE-522 ConferenceSABCS 2021
31 January, 2022 17:45
Presented ByDr Rachel Giles, Medicom
ConferenceSABCS 2021
10 January, 2022 20:59
TrialKEYNOTE-173, Phase 1b ; I-SPY 2, Phase 2 ; KEYNOTE-522, Phase 3 ConferenceSABCS 2019
13 February, 2020 22:56
Presented ByProf. Peter Schmid, Queen Mary University of London, UK
TrialPhase 3, KEYNOTE-522 ConferenceESMO 2019
26 November, 2019 23:12